Clinical Trials Directory

Trials / Completed

CompletedNCT05009914

A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG.

Assessing a New Way of Cardiac Denervation to Reduce the Incidence of Atrial Fibrillation After Coronary Artery Bypass Grafting.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
430 (actual)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, random controlled trial(RCT) study. 430 patients undergoing coronary artery bypass grafting were enrolled. Our new way of cardiac denervation, defined as excision of Marshall ligament and Waterstone fat pad, was performed in 215 patients, and the other 215 patients were used as control subjects. All the patients need to equip with electronic monitor to record heart rhythms within 6 days after CABG. The investigators will compare the incidence of postoperative atrial fibrillation between two groups, and follow up 30 days after discharged.

Conditions

Interventions

TypeNameDescription
PROCEDUREcardiac denervationExcision of Marshall ligament and Waterstone fat pad during CABG.

Timeline

Start date
2022-08-15
Primary completion
2023-12-13
Completion
2024-01-30
First posted
2021-08-18
Last updated
2024-05-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05009914. Inclusion in this directory is not an endorsement.